435 related articles for article (PubMed ID: 28694655)
1. Antioxidant dietary approach in treatment of fatty liver: New insights and updates.
Ferramosca A; Di Giacomo M; Zara V
World J Gastroenterol; 2017 Jun; 23(23):4146-4157. PubMed ID: 28694655
[TBL] [Abstract][Full Text] [Related]
2. Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function.
Rafiei H; Omidian K; Bandy B
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30832407
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Pan MH; Lai CS; Tsai ML; Ho CT
Mol Nutr Food Res; 2014 Jan; 58(1):147-71. PubMed ID: 24302567
[TBL] [Abstract][Full Text] [Related]
4. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
Xu L; Nagata N; Ota T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775341
[TBL] [Abstract][Full Text] [Related]
5. Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.
Li Z; Zhang H; Li Y; Chen H; Wang C; Wong VKW; Jiang Z; Zhang W
Phytomedicine; 2020 Apr; 69():153209. PubMed ID: 32240928
[TBL] [Abstract][Full Text] [Related]
6. A Review of the Effects of Fucoxanthin on NAFLD.
Sayuti NH; Muhammad Nawawi KN; Goon JA; Mokhtar NM; Makpol S; Tan JK
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111187
[TBL] [Abstract][Full Text] [Related]
7. Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation.
Cione E; La Torre C; Cannataro R; Caroleo MC; Plastina P; Gallelli L
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878082
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
Xiao J; Ho CT; Liong EC; Nanji AA; Leung TM; Lau TY; Fung ML; Tipoe GL
Eur J Nutr; 2014 Feb; 53(1):187-99. PubMed ID: 23515587
[TBL] [Abstract][Full Text] [Related]
10. Targeting Mitochondria for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: Polyphenols as a Non-pharmacological Approach.
Zapata J; Castro-Sepulveda M; Soto-Alarcon S; Alvarez D; Bustamante A; Villarroel G; Gallardo A; Garcia-Diaz DF; Valenzuela R; Echeverria F
Curr Med Chem; 2023; 30(26):2977-2995. PubMed ID: 36214303
[TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol and other polyphenols in hepatic steatosis.
Aguirre L; Portillo MP; Hijona E; Bujanda L
World J Gastroenterol; 2014 Jun; 20(23):7366-80. PubMed ID: 24966607
[TBL] [Abstract][Full Text] [Related]
12. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice.
Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T
Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760
[TBL] [Abstract][Full Text] [Related]
13. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Cicero AFG; Colletti A; Bellentani S
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142943
[TBL] [Abstract][Full Text] [Related]
14. Phytochemicals in cancer prevention and therapy: truth or dare?
Russo M; Spagnuolo C; Tedesco I; Russo GL
Toxins (Basel); 2010 Apr; 2(4):517-51. PubMed ID: 22069598
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
16. Novel insights of dietary polyphenols and obesity.
Wang S; Moustaid-Moussa N; Chen L; Mo H; Shastri A; Su R; Bapat P; Kwun I; Shen CL
J Nutr Biochem; 2014 Jan; 25(1):1-18. PubMed ID: 24314860
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model.
Braud L; Battault S; Meyer G; Nascimento A; Gaillard S; de Sousa G; Rahmani R; Riva C; Armand M; Maixent JM; Reboul C
J Nutr Biochem; 2017 Feb; 40():95-104. PubMed ID: 27866076
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
19. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
20. Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells.
Carrasco-Pozo C; Mizgier ML; Speisky H; Gotteland M
Chem Biol Interact; 2012 Feb; 195(3):199-205. PubMed ID: 22214982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
